Excessive capital requirement and myriad of other
complexities associated with the discovery of biologics have prompted drug
developers to adopt in silico tools / techniques to expedite the discovery
timelines
Roots Analysis is pleased to
announce the publication of its recent study, titled, “In
Silico / Computer-Aided Drug Discovery Services Market: Focus on Large
Molecules (Antibodies, Proteins, Peptides, Nucleic Acid, Gene Therapy and
Vectors), 2020-2030 (Including Structure Based Drug Discovery, Fragment Based
Drug Discovery, Ligand Based Drug Discovery, Target Based Drug Discovery /
Multi-Target Drug Design, Interface Based Drug Discovery, Approaches).”
The
report features an extensive study on the current landscape
and the likely future potential of the companies offering services for the
discovery of large molecule drugs based on the use of in silico tools and
techniques. The study features an in-depth analysis, highlighting the capabilities
of various industry stakeholders. In addition to other elements, the report
includes:
§
A detailed assessment of the current market landscape of companies
offering in silico drug discovery services for large molecules.
§
Elaborate profiles of key industry players that offer a
wide range of in silico drug discovery services (shortlisted on the
basis of the company size).
§
A detailed peer group-based benchmarking analysis, comparing
the involved players based on several relevant parameters related to company
and services.
§
An insightful competitiveness analysis featuring a
four-dimensional bubble chart, highlighting the key players in this domain.
§
A detailed analysis assessing the current opportunity
within in silico drug discovery services market.
§
A discussion on the various business strategies that can be
adopted by in silico drug discovery service providers in order to maintain a
competitive edge in this industry.
§
An insightful analysis highlighting the cost saving
potential associated with the use of in silico approaches in the drug discovery
process.
§
A case study comparing the key challenges associated with
the discovery and production of large molecules.
§
Insights from an industry-wide survey, featuring inputs
solicited from various experts in this domain.
§
A discussion on the upcoming computational approaches that
are being adopted for drug discovery purposes.
§
A case study highlighting several non-computational methods
/ technologies used in drug discovery process.
§
A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below)
§
Key Drug Discovery Steps
§
Target Identification
§
Target Validation
§
Hit Generation
§
Hit-to-Lead
§
Lead Optimization
§
Type of Large Molecule
§
Antibodies
§
Proteins
§
Peptides
§
Nucleic Acids
§
Vectors
§
Company Size
§
Small
§
Mid-sized
§
Large
§
Target therapeutic Area
§
Autoimmune Disorders
§
Blood Disorders
§
Cardiovascular Disorders
§
Gastrointestinal and Digestive Disorders
§
Hormonal Disorders
§
Human Immunodeficiency Virus (HIV) / Acquired
Immunodeficiency Syndrome (AIDS)
§
Infectious Diseases
§
Metabolic Disorders
§
Mental Disorders
§
Musculoskeletal Disorders
§
Neurological Disorders
§
Oncological Disorders
§
Respiratory Disorders
§
Skin Disorders
§
Urogenital Disorders
§
Others
§
Type of Sponsor
§
Industry Players
§
Non-Industry Players
§
Key Geographical Regions
§
North America
§
Europe
§
Asia-Pacific
§
Transcripts of interviews held with the following senior
level representatives of stakeholder companies
§
John L Kulp (Chief Executive Officer and Chief Technical
Officer, Conifer Point Pharmaceuticals)
§
Sven Benson (Founder, candidum)
§
Mark Whittaker (Senior Vice President, Evotec)
§
Edelmiro Moman (Scientific Consultant and Teacher,
ProSciens)
Key
companies covered in the report
§
Abzena
§
BioDuro
§
BioNTech
§
ChemPartner
§
Creative Biostructure
§
GenScript
§
LakePharma
§
Sundia MediTech
§
Sygnature Discovery
§
Viva Biotech
For
more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/in-silico-drug-discovery/298.html
Other Recent Offerings
1.
DNA-Encoded Libraries: Platforms and
Services Market
2.
Global Stem Cells Market: Focus on
Clinical Therapies, 2020–2030
3.
Companion Diagnostics Services
Market, 2020-2030
About Roots Analysis
Roots
Analysis is one of the fastest growing market research companies, sharing fresh
and independent perspectives in the bio-pharmaceutical industry. The in-depth
research, analysis and insights are driven by an experienced leadership team
which has gained many years of significant experience in this sector. If you’d
like help with your growing business needs, get in touch at
info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav
Chaudhary
+1
(415) 800 3415
gaurav.chaudhary@rootsanalysis.com
